Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Meningococcal infections vaccine - Pfizer

Next Previous
Search
Drug Profile

Meningococcal infections vaccine - Pfizer

Alternative Names: MenABCWY - Pfizer; PENBRAYA™; PF-06886992

Latest Information Update: 10 Mar 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Pfizer
  • Class Meningococcal vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Registered Meningococcal infections

Most Recent Events

  • 20 Feb 2025 Regulatory submission withdrawn for Meningococcal infections (In adolescents, In children, Prevention, In adults) in European Union (IM)
  • 19 Sep 2024 Preregistration for Meningococcal infections (In adolescents, In children, Prevention, In adults) in European Union (IM), In between 16-19 September 2024
  • 05 Jan 2024 Pfizer completes a phase IIb trial in Meningococcal infections (In children, In adolescents, Prevention) in USA (IM) (NCT04440176) (EudraCT2019-004923-19)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top